Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company... see more

TSXV:MPH - Post Discussion

Medicure Inc > another 200,000 carrots eaten. Soon he will be gone.
View:
Post by Checkout on Dec 22, 2020 11:44am

another 200,000 carrots eaten. Soon he will be gone.

Filing Details

 
 
Issuer Name
Medicure Inc.
Insider Name
Medicure Inc.
Relationship as filed with regulators
1 - Issuer
Transaction ID
3639770
Filing Date
Dec 10, 2020
Transaction Date
Nov 23, 2020
Security Type
Common Shares
Transaction Nature
38 - Redemption, retraction, cancellation, repurchase
Ownership Type
Direct Ownership
Registered Holder
 
# or Value Acquired or Disposed of
200,000
Unit Price or Exercise Price
$0.800
Closing Balance
200,000
Conversion or Exercise Price
0.000
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities